ST段抬高型心肌梗死晚期持续微血管阻塞对不良左心室重构的影响:一项心脏磁共振研究
一项前瞻性注册研究纳入471例再灌注STEMI患者,于梗死后7天和198天行心脏磁共振检查,发现1周时微血管阻塞(MVO)发生率为44%,持续至随访时仅6%;持续MVO患者不良左心室重构(ALVR)发生率显著高于无MVO或仅1周MVO患者,且持续MVO与左心室容积指数变化独立相关。
要点
- 再灌注STEMI后1周MVO发生率为44%,随访时持续MVO仅占6%。
- 持续MVO患者ALVR-LVEDVI发生率为50%,ALVR-LVESVI为53%,显著高于无MVO或仅1周MVO者。
- 1周时MVO范围和心肌内出血是随访时MVO程度的独立相关因素。
核心结论
- STEMI慢性期小部分患者MVO持续存在,并对左心室重构产生不良影响;作者认为这些发现提示需要进一步研究微血管损伤修复。
研究设计与样本
- 前瞻性注册研究,纳入471例STEMI患者,于梗死后7天(IQR 5-10天)和198天(IQR 167-231天)行心脏磁共振检查。
关键影像表现/征象
- 1周时MVO(≥1个节段)发生于209例(44%),随访时持续MVO见于30例(6%)。
- 无MVO患者262例(56%),仅1周MVO患者179例(38%)。
- 持续MVO组ALVR-LVEDVI发生率为50%,无MVO组为22%,仅1周MVO组为27%(P=0.003)。
- 持续MVO组ALVR-LVESVI发生率为53%,无MVO组为20%,仅1周MVO组为21%(P<0.001)。
诊断标准与关键数值
- MVO定义为≥1个节段。
- ALVR定义为随访CMR时左心室舒张末期容积指数(LVEDVI)或左心室收缩末期容积指数(LVESVI)相对增加>15%。
- 调整后,随访时持续MVO(≥1个节段)与ΔLVEDVI(相对增加,%)独立相关(P<0.001),与ΔLVESVI独立相关(P<0.001)。
- 与1:1倾向性评分匹配的30例仅1周MVO患者相比,持续MVO患者更常出现ALVR-LVEDVI(12% vs 50%;P=0.003)和ALVR-LVESVI(12% vs 53%;P=0.001)。
临床应用与阅片要点
- 作者认为这些发现提示需要进一步研究微血管损伤修复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Little is known about the occurrence and implications of persistent microvascular obstruction (MVO) after reperfused ST-segment elevation myocardial infarction (STEMI).
OBJECTIVES: The authors used cardiac magnetic resonance (CMR) to characterize the impact of persistent MVO on adverse left ventricular remodeling (ALVR).
METHODS: A prospective registry of 471 STEMI patients underwent CMR 7 (IQR: 5-10) days and 198 (IQR: 167-231) days after infarction. MVO (≥1 segment) and ALVR (relative increase >15% at follow-up CMR) of left ventricular end-diastolic index (LVEDVI) and left ventricular end-systolic volume index (LVESVI) were determined.
RESULTS: One-week MVO occurred in 209 patients (44%) and persisted in 30 (6%). The extent of MVO (P = 0.026) and intramyocardial hemorrhage (P = 0.001) at 1 week were independently associated with the magnitude of MVO at follow-up CMR. Compared with patients without MVO (n = 262, 56%) or with MVO only at 1 week (n = 179, 38%), those with persistent MVO at follow-up (n = 30, 6%) showed higher rates of ALVR-LVEDVI (22%, 27%, and 50%; P = 0.003) and ALVR-LVESVI (20%, 21%, and 53%; P < 0.001). After adjustment, persistent MVO at follow-up (≥1 segment) was independently associated with ΔLVEDVI (relative increase, %) (P < 0.001) and ΔLVESVI (P < 0.001). Compared with a 1:1 propensity score-matched population on CMR variables made up of 30 patients with MVO only at 1 week, patients with persistent MVO more frequently displayed ALVR-LVEDVI (12% vs 50%; P = 0.003) and ALVR-LVESVI (12% vs 53%; P = 0.001).
CONCLUSIONS: MVO persists in a small percentage of patients in chronic phase after STEMI and exerts deleterious effects in terms of LV remodeling. These findings fuel the need for further research on microvascular injury repair.
引用
- Bodi V, Gavara J, Lopez-Lereu MP, et al. Impact of Persistent Microvascular Obstruction Late After STEMI on Adverse LV Remodeling: A CMR Study. JACC Cardiovasc Imaging. 2023. PMID: 37052556. doi:10.1016/j.jcmg.2023.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。